These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 23527049)

  • 21. Incidental abnormal FDG uptake in the prostate on 18-fluoro-2-deoxyglucose positron emission tomography-computed tomography scans.
    Kang PM; Seo WI; Lee SS; Bae SK; Kwak HS; Min K; Kim W; Kang DI
    Asian Pac J Cancer Prev; 2014; 15(20):8699-703. PubMed ID: 25374193
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diagnostic value of positron emission tomography combined with computed tomography for evaluating patients with septic shock of unknown origin.
    Kluge S; Braune S; Nierhaus A; Wichmann D; Derlin T; Mester J; Klutmann S
    J Crit Care; 2012 Jun; 27(3):316.e1-7. PubMed ID: 22176803
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cyclophosphamide for large vessel vasculitis: assessment of response by PET/CT.
    Henes JC; Mueller M; Pfannenberg C; Kanz L; Kötter I
    Clin Exp Rheumatol; 2011; 29(1 Suppl 64):S43-8. PubMed ID: 21385544
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of 18F-FDG PET/CT in the evaluation of pediatric transplant patients.
    Yang J; Zhuang H
    Hell J Nucl Med; 2015; 18(2):136-9. PubMed ID: 26187213
    [TBL] [Abstract][Full Text] [Related]  

  • 25. ¹⁸F-Fluorodeoxyglucose positron emission tomography/computed tomography finds answers in cancer patients with increasing tumor markers and negative or equivocal conventional imaging modalities.
    Salem SS; Shahin MA
    Nucl Med Commun; 2012 Mar; 33(3):313-21. PubMed ID: 22237387
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Optimal use of [18F]FDG-PET/CT in patients with fever or inflammation of unknown origin.
    Mulders-Manders CM; Kouijzer IJ; Janssen MJ; Oyen WJ; Simon A; Bleeker-Rovers CP
    Q J Nucl Med Mol Imaging; 2021 Mar; 65(1):51-58. PubMed ID: 31271266
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [18F]FDG-PET/CT for the diagnosis of patients with fever of unknown origin.
    Gafter-Gvili A; Raibman S; Grossman A; Avni T; Paul M; Leibovici L; Tadmor B; Groshar D; Bernstine H
    QJM; 2015 Apr; 108(4):289-98. PubMed ID: 25208896
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography-guided management of suspected recurrent papillary thyroid carcinoma: long-term follow-up with tumour marker responses.
    Dennis K; Hay JH; Wilson DC
    Clin Oncol (R Coll Radiol); 2012 Dec; 24(10):e168-72. PubMed ID: 22944464
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Imaging giant cell arteritis and Aortitis in contrast enhanced 18F-FDG PET/CT: Which imaging score correlates best with laboratory inflammation markers?
    Olthof SC; Krumm P; Henes J; Nikolaou K; la Fougère C; Pfannenberg C; Schwenzer N
    Eur J Radiol; 2018 Feb; 99():94-102. PubMed ID: 29362158
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Molecular neuroimaging in the study of cognitive impairment: contribution of the cerebral blood flow SPECT with 99mTc-HMPAO and 18F-FDG PET/CT scan].
    Banzo I; Quirce R; Martínez-Rodríguez I; Jiménez-Bonilla J; Portilla-Quattrociocchi H; Medina-Quiroz P; Ortega F; Rodríguez E; Mateo I; Vázquez-Higuera JL; de Arcocha M; Carril JM
    Rev Esp Med Nucl; 2011; 30(5):301-6. PubMed ID: 21640440
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The value of 18F-fluorodeoxyglucose positron emission tomography/computed tomography in carcinoma of an unknown primary: diagnosis and follow-up.
    Yapar Z; Kibar M; Yapar AF; Paydas S; Reyhan M; Kara O; Buyukdereli G; Aydin M; Kelle AP; Unal I; Disel U; Yavuz S; Sahin B; Erkisi M
    Nucl Med Commun; 2010 Jan; 31(1):59-66. PubMed ID: 19952921
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of F-18 Fluorodeoxyglucose PET/CT in Granulomatosis with Polyangiitis.
    Nelson DR; Johnson GB; Cartin-Ceba R; Specks U
    Sarcoidosis Vasc Diffuse Lung Dis; 2016 Jan; 32(4):342-52. PubMed ID: 26847102
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The prognostic value of baseline (18)F-FDG PET/CT in steroid-naïve large-vessel vasculitis: introduction of volume-based parameters.
    Dellavedova L; Carletto M; Faggioli P; Sciascera A; Del Sole A; Mazzone A; Maffioli LS
    Eur J Nucl Med Mol Imaging; 2016 Feb; 43(2):340-348. PubMed ID: 26250689
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Change of maximum standardized uptake value slope in dynamic triphasic [18F]-fluorodeoxyglucose positron emission tomography/computed tomography distinguishes malignancy from postradiation inflammation in head-and-neck squamous cell carcinoma: a prospective trial.
    Anderson CM; Chang T; Graham MM; Marquardt MD; Button A; Smith BJ; Menda Y; Sun W; Pagedar NA; Buatti JM
    Int J Radiat Oncol Biol Phys; 2015 Mar; 91(3):472-9. PubMed ID: 25680593
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diagnostic accuracy of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography in differentiated thyroid cancer patients with elevated thyroglobulin and negative (131)I whole body scan: evaluation by thyroglobulin level.
    Na SJ; Yoo IeR; O JH; Lin C; Lin Q; Kim SH; Chung SK
    Ann Nucl Med; 2012 Jan; 26(1):26-34. PubMed ID: 21971605
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lesson of the month 1: Large vessel vasculitis - a diagnostic challenge and the role of 18-fluorodeoxyglucose positron emission tomography.
    Allard A; Mootoo R
    Clin Med (Lond); 2017 Jul; 17(4):369-370. PubMed ID: 28765420
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prospective comparison of combined 18F-FDG and 18F-NaF PET/CT vs. 18F-FDG PET/CT imaging for detection of malignancy.
    Lin FI; Rao JE; Mittra ES; Nallapareddy K; Chengapa A; Dick DW; Gambhir SS; Iagaru A
    Eur J Nucl Med Mol Imaging; 2012 Feb; 39(2):262-70. PubMed ID: 22065013
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diagnostic contribution of (18)F-FDG-PET/CT in fever of unknown origin.
    Tokmak H; Ergonul O; Demirkol O; Cetiner M; Ferhanoglu B
    Int J Infect Dis; 2014 Feb; 19():53-8. PubMed ID: 24295559
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of 2-[18F] fluoro-2-deoxy-D-glucose-positron emission tomography/computed tomography in the post-therapy surveillance of breast cancer.
    Chang HT; Hu C; Chiu YL; Peng NJ; Liu RS
    PLoS One; 2014; 9(12):e115127. PubMed ID: 25517451
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prediction of survival and evaluation of diagnostic accuracy whole body 18F-fluoro-2-deoxyglucose positron emission tomography/computed tomography in the detection carcinoma of unknown primary origin.
    Tamam MO; Mulazimoglu M; Guveli TK; Tamam C; Eker O; Ozpacaci T
    Eur Rev Med Pharmacol Sci; 2012 Dec; 16(15):2120-30. PubMed ID: 23280029
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.